Cargando…
Miocarditis por SARS-CoV-2. Una breve revisión
Myocarditis is an important cardiovascular complication of COVID-19, a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been observed that hospitalized patients with pre-existing cardiac disease are at higher risk for the development of this complication. It is...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Cardiología. Published by Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902291/ http://dx.doi.org/10.1016/j.rccl.2023.01.003 |
_version_ | 1784883227451719680 |
---|---|
author | Cahuapaza-Gutierrez, Nelson Luis Campos-Escalante, Tsuriel Sofía |
author_facet | Cahuapaza-Gutierrez, Nelson Luis Campos-Escalante, Tsuriel Sofía |
author_sort | Cahuapaza-Gutierrez, Nelson Luis |
collection | PubMed |
description | Myocarditis is an important cardiovascular complication of COVID-19, a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been observed that hospitalized patients with pre-existing cardiac disease are at higher risk for the development of this complication. It is predominantly male, with the most affected population being adults over 50 years of age and pediatrics; however, its incidence and prevalence are not completely known. This disease is caused by direct and indirect lesions caused by SARS-CoV-2 infection to the myocardiocyte and other cells. Clinical manifestations vary from mild, such as fatigue and dyspnea, to severe, such as cardiogenic shock. Tests for the detection of this pathology are laboratory, imaging and histological. In this article we briefly review SARS-CoV-2 myocarditis in epidemiology, pathophysiology, clinic, diagnosis, treatment, as well as vaccination myocarditis. |
format | Online Article Text |
id | pubmed-9902291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99022912023-02-07 Miocarditis por SARS-CoV-2. Una breve revisión Cahuapaza-Gutierrez, Nelson Luis Campos-Escalante, Tsuriel Sofía Rec. Cardioclinics Artículo De Revisión Myocarditis is an important cardiovascular complication of COVID-19, a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been observed that hospitalized patients with pre-existing cardiac disease are at higher risk for the development of this complication. It is predominantly male, with the most affected population being adults over 50 years of age and pediatrics; however, its incidence and prevalence are not completely known. This disease is caused by direct and indirect lesions caused by SARS-CoV-2 infection to the myocardiocyte and other cells. Clinical manifestations vary from mild, such as fatigue and dyspnea, to severe, such as cardiogenic shock. Tests for the detection of this pathology are laboratory, imaging and histological. In this article we briefly review SARS-CoV-2 myocarditis in epidemiology, pathophysiology, clinic, diagnosis, treatment, as well as vaccination myocarditis. Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. 2023 2023-02-07 /pmc/articles/PMC9902291/ http://dx.doi.org/10.1016/j.rccl.2023.01.003 Text en © 2023 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Artículo De Revisión Cahuapaza-Gutierrez, Nelson Luis Campos-Escalante, Tsuriel Sofía Miocarditis por SARS-CoV-2. Una breve revisión |
title | Miocarditis por SARS-CoV-2. Una breve revisión |
title_full | Miocarditis por SARS-CoV-2. Una breve revisión |
title_fullStr | Miocarditis por SARS-CoV-2. Una breve revisión |
title_full_unstemmed | Miocarditis por SARS-CoV-2. Una breve revisión |
title_short | Miocarditis por SARS-CoV-2. Una breve revisión |
title_sort | miocarditis por sars-cov-2. una breve revisión |
topic | Artículo De Revisión |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902291/ http://dx.doi.org/10.1016/j.rccl.2023.01.003 |
work_keys_str_mv | AT cahuapazagutierreznelsonluis miocarditisporsarscov2unabreverevision AT camposescalantetsurielsofia miocarditisporsarscov2unabreverevision |